Then & Now – The Kidney Protection Masterclass – EDT Session – October 1, 2020 17h 30

Learning Objectives

• Describe the changing trends in the morbidity and mortality of renal disease in Canada
• Integrate and prioritize the newer therapies in the prevention and treatment of renal disease in patients with and without vascular disease
• Appreciate the safety and efficacy of newer therapies in the prevention of renalvascular events
• Understand how renal disease accelerates vascular and cardiac outcomes

Agenda

Faculty

Lawrence A. Leiter
MD, FRCPC, FACP, FACE, FAHA, FACC
Chair – English Webinar
Endocrinologist, St. Michael’s Hospital;
Professor of Medicine and Nutritional
Sciences, University of Toronto,
Toronto, ON

Mohammed Al-Omran
MD, MSc, FRCSC
Co-Chair
Head of Vascular Surgery,
St. Michael’s Hospital
Professor of Surgery, and, Pharmacology and Toxicology
University of Toronto,
Toronto, ON

Adeera Levin
MD, FRCPC, CM
Professor of Medicine and
Head of Nephrology,
University of British Columbia;
Executive Director,
B.C. Provincial Renal Agency,
Vancouver, BC

Louise Moist
MD, MSc, FRCPC
Nephrologist, London Health Sciences Centre – Victoria Hospital;
Professor of Medicine and Epidemiology & Biostatistics,
Western University,
London, ON

Vlado Perkovic
MBBS, PhD, FRACP, FASN, FAHMS
Dean of Medicine and Scientia Professor, UNSW;
Professorial Fellow, The George Institute;
Staff Specialist in Nephrology, Royal North Shore Hospital,
Sydney, NSW, Australia

Veronica Silva
MD, FRCPC
Nephrologist,
Clinical Investigator,
Institute for Better Health
Trillium Health Partners
Co-founder and Co-Chair
Mississauga Hypertension Clinic, Clinical Lecturer, University of Toronto,
Toronto, ON

Subodh Verma
MD, PhD, FRCSC, FAHA
Cardiac Surgeon, St. Michael’s Hospital;
Professor of Surgery and Pharmacology & Toxicology, University of Toronto;
Canada Research Chair in Cardiovascular Surgery,
Toronto, ON